首页> 中文期刊> 《中国继续医学教育》 >超小剂量的地西他滨联合CAG方案治疗中高危骨髓增生异常综合征及难治性白血病的效果分析

超小剂量的地西他滨联合CAG方案治疗中高危骨髓增生异常综合征及难治性白血病的效果分析

             

摘要

Objective Analysis of ultra small doses of land west of the CAG combination regimen for high-risk myelodysplastic syndrome (MDS) and the effect of refractory leukemia (AML).Methods 120 cases of MDS and AML patients as the research object from May 2012 to May 2014, randomly divided into control group (60 cases) and observation group (60 cases). Control group take the use ultra small doses of his west marina treatment, observation group adopt ultra small doses of west the CAG regimen for combination.ResultsThe treatment of patients with observation group total effective rate and total survival time observation indexes were signiifcantly better than that of control group (P<0.05).Conclusion The small doses of land west of the CAG combination regimen for high-risk myelodysplastic syndrome and refractory leukemia effect is remarkable.%目的:分析超小剂量的地西他滨联合CAG方案治疗中高危骨髓增生异常综合征(MDS)及难治性白血病(AML)的效果。方法选取我院2012年5月~2014年5月收治的120例MDS或AML患者作为研究对象,随机分成对照组(60例)和观察组(60例)。对照组采取单用超小剂量的地西他滨治疗,观察组采取超小剂量的地西他滨联合CAG方案治疗。结果观察组患者的治疗总有效率及总生存时间等观察指标均优于对照组(P<0.05)。结论超小剂量的地西他滨联合CAG方案治疗中高危骨髓增生异常综合征及难治性白血病的效果显著。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号